How to buy SpringWorks Therapeutics stock
Learn how to easily invest in SpringWorks Therapeutics stock.
SpringWorks Therapeutics is a biotechnology business based in the US. SpringWorks Therapeutics shares (SWTX) are listed on the NASDAQ and all prices are listed in US Dollars. SpringWorks Therapeutics employs 227 staff and has a trailing 12-month revenue of around $35 million.
How to buy SpringWorks Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SWTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
SpringWorks Therapeutics stock price (NASDAQ: SWTX)Use our graph to track the performance of SWTX stocks over time.
SpringWorks Therapeutics shares at a glance
|Latest market close||$23.72|
|52-week range||$21.04 - $34.16|
|50-day moving average||$28.00|
|200-day moving average||$27.36|
|Wall St. target price||$50.17|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.92|
Buy SpringWorks Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy SpringWorks Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
SpringWorks Therapeutics price performance over time
|1 week (2023-09-15)||-9.95%|
|1 month (2023-08-24)||-14.80%|
|3 months (2023-06-23)||-9.12%|
|6 months (2023-03-24)||-5.01%|
|1 year (2022-09-23)||-5.12%|
|2 years (2021-09-24)||-65.47%|
|3 years (2020-09-24)||44.95|
|5 years (2018-09-20)||N/A|
SpringWorks Therapeutics financials
|Revenue TTM||$35 million|
|Gross profit TTM||$35 million|
|Return on assets TTM||-43.98%|
|Return on equity TTM||-76.67%|
|Market Capitalization||$1.6 billion|
TTM: trailing 12 months
SpringWorks Therapeutics share dividends
We're not expecting SpringWorks Therapeutics to pay a dividend over the next 12 months.
SpringWorks Therapeutics share price volatility
Over the last 12 months, SpringWorks Therapeutics's shares have ranged in value from as little as $21.04 up to $34.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SpringWorks Therapeutics's is 0.5763. This would suggest that SpringWorks Therapeutics's shares are less volatile than average (for this exchange).
SpringWorks Therapeutics overview
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors. The company is also developing mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas, as well as Phase 1/2a clinical trial for the treatment of NF1-PN; mirdametinib + lifirafenib, a combination therapy that is in Phase 1b/2 clinical trial in patients with advanced or refractory solid tumors; and mirdametinib in monotherapy and combination approaches to treat solid tumors. In addition, it develops BGB-3245, an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has collaborations with BeiGene, Ltd. and GlaxoSmithKline LLC; and license agreements with Pfizer Inc.
Frequently asked questionsWhat percentage of SpringWorks Therapeutics is owned by insiders or institutions?
Currently 6.606% of SpringWorks Therapeutics shares are held by insiders and 110.342% by institutions. How many people work for SpringWorks Therapeutics?
Latest data suggests 227 work at SpringWorks Therapeutics. When does the fiscal year end for SpringWorks Therapeutics?
SpringWorks Therapeutics's fiscal year ends in December. Where is SpringWorks Therapeutics based?
SpringWorks Therapeutics's address is: 100 Washington Boulevard, Stamford, CT, United States, 06902 What is SpringWorks Therapeutics's ISIN number?
SpringWorks Therapeutics's international securities identification number is: US85205L1070 What is SpringWorks Therapeutics's CUSIP number?
SpringWorks Therapeutics's Committee on Uniform Securities Identification Procedures number is: 85205L107
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert